ABSTRACT
In the last decade, a novel class of nanomaterials based exclusively on carbon (Fig. 11.1) has been explored in the fields of nanobiotechnology and nanomedicine. Several proof-of-concept studies have demonstrated that fullerenes, CNTs, carbon nanohorns (CNHs), nanodiamonds, and, more recently, graphene may offer new tools for diagnosis and treatment of various diseases [1-4]. Amongst those CNMs, CNTs and graphene have both attracted a lot of interest from biomedical researchers, owing to their unique combination of chemical and physical properties.
